Annual Long Term Debt
$686.00 K
-$3.51 M-83.64%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual long term debt is $686.00 thousand, with the most recent change of -$3.51 million (-83.64%) on December 31, 2023.
- ENLV annual long term debt is now -87.27% below its all-time high of $5.39 million, reached on December 31, 2021.
Performance
ENLV Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$419.00 K
-$80.00 K-16.03%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly long term debt is $419.00 thousand, with the most recent change of -$80.00 thousand (-16.03%) on September 30, 2024.
- Over the past year, ENLV quarterly long term debt has dropped by -$3.40 million (-89.03%).
- ENLV quarterly long term debt is now -92.22% below its all-time high of $5.39 million, reached on December 31, 2021.
Performance
ENLV Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ENLV Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.6% | -89.0% |
| 3 y3 years | - | -89.5% |
| 5 y5 years | - | -89.5% |
ENLV Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.3% | at low | -92.2% | at low |
| 5 y | 5-year | -87.3% | at low | -92.2% | +77.5% |
| alltime | all time | -87.3% | at low | -92.2% | +77.5% |
Enlivex Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $419.00 K(-16.0%) |
| Jun 2024 | - | $499.00 K(-15.0%) |
| Mar 2024 | - | $587.00 K(-14.4%) |
| Dec 2023 | $686.00 K | $686.00 K(-82.0%) |
| Sep 2023 | - | $3.82 M(+3.1%) |
| Jun 2023 | - | $3.70 M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.00 M(-4.7%) |
| Dec 2022 | $4.19 M(-22.2%) | $4.19 M(-9.0%) |
| Sep 2022 | - | $4.61 M(-14.4%) |
| Dec 2021 | $5.39 M | $5.39 M(+980.0%) |
| Sep 2020 | - | $499.00 K(+111.4%) |
| Jun 2020 | - | $236.00 K |
FAQ
- What is Enlivex Therapeutics annual long term debt?
- What is the all time high annual long term debt for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual long term debt year-on-year change?
- What is Enlivex Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly long term debt year-on-year change?
What is Enlivex Therapeutics annual long term debt?
The current annual long term debt of ENLV is $686.00 K
What is the all time high annual long term debt for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual long term debt is $5.39 M
What is Enlivex Therapeutics annual long term debt year-on-year change?
Over the past year, ENLV annual long term debt has changed by -$3.51 M (-83.64%)
What is Enlivex Therapeutics quarterly long term debt?
The current quarterly long term debt of ENLV is $419.00 K
What is the all time high quarterly long term debt for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly long term debt is $5.39 M
What is Enlivex Therapeutics quarterly long term debt year-on-year change?
Over the past year, ENLV quarterly long term debt has changed by -$3.40 M (-89.03%)